Theresa Mallick-Searle, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Theresa Mallick-Searle’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C13587 · Cancelled
Licence status: Cancelled · since 1951 · Case Western Reserve University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$31,391
Medicare paid this office $31,391 for 255 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 178 | $21,371 | $91 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 39 | $7,598 | $86 |
| Short return visit | 12 | $614 | $47 |
| Other procedure on skin, mucous membrane, and tissue | 16 | $594 | $33 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 30 | $593 | $19 |
Who their Medicare patients are
255 Original Medicare patients in 2024. Average age 70 · Under 65 23% · 85 and older 8% · Women 71% · Also on Medicaid 26% · Health risk score 1.32. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 65% · Depression 33% · Diabetes 26% · Chronic kidney disease 20% · Coronary heart disease 19% · Atrial fibrillation 16% · Cancer 15% · Heart failure 14% · COPD 13% · Stroke 8%.
The office billed $226,223, Medicare allowed $41,456 and paid $31,391; for 402 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 255 | 402 | 70 | 1.32 | $226,223 | $31,391 |
| 2023 | 212 | 331 | 68 | 1.39 | $188,413 | $23,090 |
| 2022 | 282 | 456 | 67 | 1.65 | $276,613 | $30,054 |
| 2021 | 193 | 343 | 65 | 1.53 | $224,999 | $24,816 |
| 2020 | 136 | 250 | 62 | 1.51 | $140,435 | $15,413 |
| 2019 | 127 | 209 | 63 | 1.51 | $73,502 | $13,198 |
| 2018 | 136 | 238 | 62 | 1.55 | $67,981 | $14,195 |
| 2017 | 89 | 153 | 66 | 1.42 | $43,514 | $8,665 |
| 2016 | 151 | 264 | 64 | 1.55 | $68,618 | $14,794 |
| 2015 | 147 | 242 | 64 | 1.44 | $55,053 | $13,496 |
| 2014 | 163 | 277 | 64 | 1.40 | $57,566 | $15,297 |
| 2013 | 119 | 228 | 63 | 1.69 | $42,437 | $11,653 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 173 | $14,885 | $69 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 38 | $7,113 | $83 |
2022: 4 services
| Return visit (30+ min) | 215 | $20,762 | $69 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 39 | $6,420 | $74 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $1,404 | $64 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 24 | $382 | $13 |
2021: 3 services
| Return visit (30+ min) | 141 | $13,746 | $70 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 35 | $8,250 | $87 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 12 | $271 | $21 |
2020: 2 services
| Return visit (30+ min) | 101 | $7,573 | $53 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 35 | $5,682 | $85 |
2019: 2 services
| Return visit (30+ min) | 98 | $7,119 | $56 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 29 | $5,576 | $81 |
2018: 2 services
| Return visit (30+ min) | 110 | $9,300 | $55 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 25 | $4,426 | $80 |
2017: 2 services
| Return visit (30+ min) | 79 | $6,263 | $51 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 12 | $2,329 | $80 |
2016: 2 services
| Return visit (30+ min) | 133 | $12,575 | $54 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 17 | $2,032 | $75 |
2015: 1 service
| Return visit (30+ min) | 138 | $11,833 | $55 |
2014: 1 service
| Return visit (30+ min) | 154 | $14,168 | $55 |
2013: 1 service
| Return visit (30+ min) | 118 | $11,579 | $51 |
Medicaid work
$212 in 2022
Medicaid paid $212 for 28 billed services this clinician did in 2022, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 28 | $212 |
| 2022 | 28 | 1 | 16 | $212 |
| 2021 | 12 | 1 | 12 | $205 |
| 2020 | 41 | 2 | 17 | $2,084 |
| 2019 | 15 | 1 | 14 | $383 |
See the largest Medicaid services in earlier years
2021
| Chemodenervation of muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (eg, for chronic migraine) | 12 | $205 |
2020
| Return visit (30+ min) | 29 | $1,187 |
| Chemodenervation of muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (eg, for chronic migraine) | 12 | $897 |
2019
| Return visit (30+ min) | 15 | $383 |
Drugs they prescribed that Part D paid
$50,648
Pharmacies billed $50,648 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
145 generic and 34 brand-name prescriptions · $50,648 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Emgality | Migraine | 11 | $7,623 | $693 |
| Pregabalin | None | 15 | $2,207 | $147 |
| Gabapentin | None | 34 | $616 | $18 |
| Duloxetine | None | 11 | $149 | $14 |
Year by year
| 2024 | 179 | 61 | None | 19% | $50,648 |
| 2023 | 168 | 52 | None | 28% | $65,180 |
| 2022 | 190 | 54 | 10% (18) | 29% | $52,597 |
| 2021 | 245 | 48 | 5% (13) | 40% | $90,873 |
| 2020 | 299 | 55 | None | 22% | $53,804 |
| 2019 | 290 | 68 | 11% (33) | 18% | $46,338 |
| 2018 | 326 | 64 | 6% (20) | 20% | $51,603 |
| 2017 | 266 | 51 | 8% (22) | 14% | $23,923 |
| 2016 | 327 | 66 | 14% (44) | 23% | $46,993 |
| 2015 | 318 | 66 | 20% (63) | 26% | $46,511 |
| 2014 | 365 | 78 | 21% (77) | 30% | $70,782 |
| 2013 | 236 | 56 | 41% (97) | 40% | $41,581 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Nurtec Odt | None | 19 | $30,320 | $1,596 |
| Emgality | Migraine | 12 | $9,052 | $754 |
| Pregabalin | None | 17 | $1,627 | $96 |
| Gabapentin | None | 28 | $651 | $23 |
| Duloxetine | None | 13 | $255 | $20 |
2022: 7 drugs
| Nurtec Odt | None | 11 | $16,074 | $1,461 |
| Aimovig | Migraine | 14 | $9,467 | $676 |
| Pregabalin | None | 25 | $1,743 | $70 |
| Lidocaine | None | 13 | $410 | $32 |
| Gabapentin | None | 18 | $345 | $19 |
| Diclofenac | None | 11 | $197 | $18 |
| Sumatriptan | None | 11 | $186 | $17 |
2021: 10 drugs
| Ubrelvy | None | 26 | $24,279 | $934 |
| Nurtec Odt | None | 15 | $19,094 | $1,273 |
| Aimovig | Migraine | 24 | $15,524 | $647 |
| Emgality | Migraine | 12 | $7,488 | $624 |
| Pregabalin | None | 15 | $2,191 | $146 |
| Lidocaine | None | 21 | $1,002 | $48 |
| Topiramate | None | 20 | $464 | $23 |
| Rizatriptan | None | 16 | $390 | $24 |
| Gabapentin | None | 22 | $345 | $16 |
| Naratriptan | None | 11 | $297 | $27 |
2020: 10 drugs
| Aimovig | Migraine | 16 | $9,781 | $611 |
| Pregabalin | None | 29 | $3,481 | $120 |
| Sumatriptan | None | 14 | $1,684 | $120 |
| Gabapentin | None | 67 | $1,377 | $21 |
| Rizatriptan | None | 18 | $639 | $36 |
| Lidocaine | None | 16 | $632 | $40 |
| Naratriptan | None | 17 | $517 | $30 |
| Diclofenac | None | 13 | $470 | $36 |
| Baclofen | None | 23 | $422 | $18 |
| Topiramate | None | 14 | $267 | $19 |
2019: 7 drugs
| Lyrica | 24 | $20,851 | $869 |
| Gabapentin | 64 | $1,853 | $29 |
| Lidocaine | 15 | $1,643 | $110 |
| Naratriptan | 17 | $822 | $48 |
| Diclofenac | 17 | $512 | $30 |
| Topiramate | 38 | $345 | $9 |
| Hydrocodone-Acetaminophen | 11 | $108 | $10 |
2018: 8 drugs
| Lyrica | 32 | $24,334 | $760 |
| Lidocaine | 42 | $8,890 | $212 |
| Butrans | 11 | $4,858 | $442 |
| Gabapentin | 69 | $1,717 | $25 |
| Duloxetine | 21 | $1,465 | $70 |
| Baclofen | 11 | $393 | $36 |
| Topiramate | 35 | $362 | $10 |
| Cyclobenzaprine | 11 | $273 | $25 |
2017: 8 drugs
| Lyrica | 26 | $13,171 | $507 |
| Duloxetine | 16 | $1,556 | $97 |
| Gabapentin | 67 | $1,424 | $21 |
| Lidocaine | 12 | $1,117 | $93 |
| Baclofen | 17 | $300 | $18 |
| Topiramate | 33 | $292 | $9 |
| Cyclobenzaprine | 15 | $184 | $12 |
| Tizanidine | 11 | $74 | $7 |
2016: 10 drugs
| Lyrica | 42 | $23,500 | $560 |
| Gralise | 14 | $7,082 | $506 |
| Lidocaine | 21 | $4,359 | $208 |
| Duloxetine | 29 | $2,756 | $95 |
| Oxycontin | 13 | $2,624 | $202 |
| Gabapentin | 80 | $2,266 | $28 |
| Baclofen | 12 | $260 | $22 |
| Tramadol | 12 | $120 | $10 |
| Nortriptyline | 14 | $115 | $8 |
| Topiramate | 13 | $105 | $8 |
2015: 8 drugs
| Lyrica | 40 | $18,789 | $470 |
| Lidocaine | 29 | $8,357 | $288 |
| Oxycontin | 12 | $3,065 | $255 |
| Duloxetine | 14 | $1,881 | $134 |
| Gabapentin | 57 | $1,451 | $25 |
| Oxycodone | 15 | $347 | $23 |
| Nortriptyline | 24 | $177 | $7 |
| Topiramate | 13 | $143 | $11 |
2014: 8 drugs
| Lyrica | 51 | $22,373 | $439 |
| Dronabinol | 15 | $12,450 | $830 |
| Lidocaine | 29 | $9,578 | $330 |
| Oxycontin | 25 | $6,597 | $264 |
| Duloxetine | 14 | $4,071 | $291 |
| Gabapentin | 111 | $3,381 | $30 |
| Endocet | 13 | $1,415 | $109 |
| Methadone | 11 | $152 | $14 |
2013: 7 drugs
| Lyrica | 36 | $13,522 | $376 |
| Dronabinol | 11 | $8,909 | $810 |
| Lidoderm | 15 | $7,514 | $501 |
| Oxycontin | 15 | $4,219 | $281 |
| Gabapentin | 23 | $692 | $30 |
| Hydrocodone-Acetaminophen | 16 | $288 | $18 |
| Methadone | 26 | $271 | $10 |
Money from drug and device companies
$66,109 in 2025
| 2025 | 11 | 116 | $52,225 | $66,109 |
| 2024 | 10 | 57 | $26,153 | $32,235 |
| 2023 | 6 | 65 | $28,379 | $36,819 |
| 2022 | 11 | 58 | $27,495 | $37,104 |
| 2021 | 9 | 34 | $18,215 | $20,520 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vertex Pharmaceuticals | Journavx | $24,791 | 49 payments
|
| Pfizer | Nurtec Odt | $18,518 | 25 payments
|
| Axsome Therapeutics | Symbravo | $13,664 | 20 payments
|
| Brixton Biosciences | Neural Ice | $3,266 | 5 payments
|
| Tonix Medicines | Tonmya | $3,178 | 5 payments
|
| Lundbeck | Vyepti | $1,033 | 3 payments
|
See all 116 published payments
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-12-30 | Journavx | $855 |
| Vertex Pharmaceuticals | Travel · 2025-12-30 | Journavx | $72 |
| Vertex Pharmaceuticals | Meals · 2025-12-30 | Journavx | $16 |
| Vertex Pharmaceuticals | Meals · 2025-12-30 | Journavx | $35 |
| Vertex Pharmaceuticals | Travel · 2025-12-30 | Journavx | $79 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-12-30 | Journavx | $1,190 |
| Vertex Pharmaceuticals | Travel · 2025-12-30 | Journavx | $11 |
| Vertex Pharmaceuticals | Travel · 2025-12-30 | Journavx | $82 |
| Pfizer | Travel · 2025-12-28 | Nurtec Odt | $124 |
| Pfizer | Travel · 2025-12-28 | Nurtec Odt | $97 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-12-24 | Journavx | $340 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-12-24 | Journavx | $1,568 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-12-24 | Journavx | $1,190 |
| Vertex Pharmaceuticals | Travel · 2025-12-18 | Journavx | $33 |
| Vertex Pharmaceuticals | Travel · 2025-12-18 | Journavx | $49 |
| Vertex Pharmaceuticals | Travel · 2025-12-18 | Journavx | $82 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-12-18 | Journavx | $1,568 |
| Vertex Pharmaceuticals | Meals · 2025-12-18 | Journavx | $106 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-12-18 | Journavx | $1,190 |
| Axsome Therapeutics | Honoraria · 2025-12-17 | Symbravo | $600 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-15 | Relistor | $54 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-12-12 | Journavx | $1,190 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-12-12 | Journavx | $428 |
| Vertex Pharmaceuticals | Travel · 2025-12-11 | Journavx | $40 |
| Vertex Pharmaceuticals | Travel · 2025-12-11 | Journavx | $109 |
| Vertex Pharmaceuticals | Meals · 2025-12-11 | Journavx | $85 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-08 | Relistor | $91 |
| Vertex Pharmaceuticals | Meals · 2025-12-01 | Journavx | $119 |
| Vertex Pharmaceuticals | Travel · 2025-12-01 | Journavx | $259 |
| Vertex Pharmaceuticals | Travel · 2025-12-01 | Journavx | $547 |
| SPR Therapeutics | Consulting · 2025-11-20 | Sprint Pns System | $875 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-11-13 | Journavx | $1,190 |
| Vertex Pharmaceuticals | Meals · 2025-11-12 | Journavx | $118 |
| Vertex Pharmaceuticals | Travel · 2025-11-12 | None | $1,568 |
| Vertex Pharmaceuticals | Travel · 2025-11-12 | None | $58 |
| Vertex Pharmaceuticals | Meals · 2025-11-12 | None | $21 |
| Vertex Pharmaceuticals | Consulting · 2025-11-12 | None | $706 |
| Vertex Pharmaceuticals | Consulting · 2025-11-12 | None | $2,354 |
| Axsome Therapeutics | Honoraria · 2025-11-10 | Symbravo | $3,400 |
| Axsome Therapeutics | Meals · 2025-11-10 | Symbravo | $122 |
| Axsome Therapeutics | Travel · 2025-11-10 | Symbravo | $153 |
| Axsome Therapeutics | Travel · 2025-11-10 | Symbravo | $562 |
| Axsome Therapeutics | Travel · 2025-11-10 | Symbravo | $55 |
| Axsome Therapeutics | Travel · 2025-11-10 | Symbravo | $40 |
| Axsome Therapeutics | Travel · 2025-11-10 | Symbravo | $54 |
| Axsome Therapeutics | Travel · 2025-11-10 | Symbravo | $65 |
| Axsome Therapeutics | Travel · 2025-11-10 | Symbravo | $31 |
| Tonix Medicines | Meals · 2025-11-08 | Tonmya | $94 |
| Pfizer | Meals · 2025-11-07 | Nurtec Odt | $83 |
| Axsome Therapeutics | Honoraria · 2025-11-07 | Symbravo | $2,800 |
| Axsome Therapeutics | Meals · 2025-11-07 | Symbravo | $63 |
| Axsome Therapeutics | Meals · 2025-11-07 | Symbravo | $110 |
| Axsome Therapeutics | Travel · 2025-11-07 | Symbravo | $112 |
| Axsome Therapeutics | Travel · 2025-11-07 | Symbravo | $660 |
| Axsome Therapeutics | Travel · 2025-11-07 | Symbravo | $123 |
| Pfizer | Travel · 2025-10-24 | Nurtec Odt | $253 |
| Pfizer | Travel · 2025-10-24 | Nurtec Odt | $253 |
| Vertex Pharmaceuticals | Meals · 2025-10-23 | Journavx | $88 |
| Pfizer | Travel · 2025-10-23 | Nurtec Odt | $266 |
| Pfizer | Travel · 2025-10-23 | Nurtec Odt | $266 |
| Pfizer | Travel · 2025-10-21 | Nurtec Odt | $107 |
| Pfizer | Travel · 2025-10-21 | Nurtec Odt | $107 |
| Vertex Pharmaceuticals | Meals · 2025-10-20 | None | $20 |
| Vertex Pharmaceuticals | Meals · 2025-10-20 | None | $26 |
| Vertex Pharmaceuticals | Meals · 2025-10-20 | None | $40 |
| Vertex Pharmaceuticals | Meals · 2025-10-20 | None | $17 |
| Vertex Pharmaceuticals | Travel · 2025-10-20 | None | $175 |
| Pfizer | Paid to speak or teach · 2025-10-20 | Nurtec Odt | $1,750 |
| Vertex Pharmaceuticals | Travel · 2025-10-19 | None | $581 |
| Vertex Pharmaceuticals | Travel · 2025-10-19 | Journavx | $290 |
| Vertex Pharmaceuticals | Travel · 2025-10-18 | Journavx | $209 |
| Vertex Pharmaceuticals | Travel · 2025-10-18 | Journavx | $570 |
| Pfizer | Paid to speak or teach · 2025-10-17 | Nurtec Odt | $2,875 |
| Pfizer | Meals · 2025-10-16 | Nurtec Odt | $115 |
| Pfizer | Meals · 2025-10-15 | Nurtec Odt | $121 |
| Tonix Medicines | Consulting · 2025-10-08 | Tonmya | $2,750 |
| Tonix Medicines | Travel · 2025-10-08 | Tonmya | $227 |
| Tonix Medicines | Meals · 2025-10-08 | Tonmya | $69 |
| Pfizer | Travel · 2025-10-07 | Nurtec Odt | $563 |
| Brixton Biosciences | Paid to speak or teach · 2025-10-02 | Neural Ice | $2,100 |
| Brixton Biosciences | Paid to speak or teach · 2025-10-02 | Neural Ice | $350 |
| Brixton Biosciences | Paid to speak or teach · 2025-10-02 | Neural Ice | $350 |
| Brixton Biosciences | Paid to speak or teach · 2025-10-02 | Neural Ice | $227 |
| Pfizer | Paid to speak or teach · 2025-09-29 | Nurtec Odt | $1,900 |
| Pfizer | Meals · 2025-09-25 | Nurtec Odt | $119 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-09-24 | Relistor | $54 |
| Axsome Therapeutics | Honoraria · 2025-09-24 | Symbravo | $1,800 |
| Pfizer | Paid to speak or teach · 2025-09-23 | Zavzpret | $393 |
| Pfizer | Consulting · 2025-09-22 | Nurtec Odt | $875 |
| Pfizer | Travel · 2025-09-04 | Nurtec Odt | $591 |
| Lundbeck | Meals · 2025-09-04 | Abilify Maintena | $64 |
| Pfizer | Paid to speak or teach · 2025-09-02 | Nurtec Odt | $1,900 |
| Tonix Medicines | Meals · 2025-09-02 | Zembrace Symtouch | $38 |
| Pfizer | Meals · 2025-08-28 | Nurtec Odt | $125 |
| Brixton Biosciences | Meals · 2025-08-22 | Neural Ice | $239 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-08-21 | Journavx | $2,720 |
| Vertex Pharmaceuticals | Travel · 2025-08-21 | Journavx | $60 |
| Vertex Pharmaceuticals | Paid to speak or teach · 2025-08-21 | Journavx | $1,568 |
| Vertex Pharmaceuticals | Travel · 2025-08-21 | Journavx | $52 |
| Pfizer | Consulting · 2025-08-21 | Zavzpret | $3,125 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-08-19 | Relistor | $104 |
| Axsome Therapeutics | Honoraria · 2025-08-06 | Symbravo | $1,800 |
| Axsome Therapeutics | Meals · 2025-08-06 | Symbravo | $116 |
| Vertex Pharmaceuticals | Travel · 2025-07-26 | Journavx | $597 |
| Vertex Pharmaceuticals | Travel · 2025-07-26 | Journavx | $198 |
| Vertex Pharmaceuticals | Meals · 2025-07-26 | Journavx | $326 |
| Axsome Therapeutics | Honoraria · 2025-07-23 | Symbravo | $1,000 |
| Lundbeck | Meals · 2025-07-18 | Vyepti | $68 |
| Pfizer | Paid to speak or teach · 2025-06-16 | Zavzpret | $1,900 |
| Pfizer | Meals · 2025-06-12 | Zavzpret | $108 |
| Pfizer | Consulting · 2025-05-22 | Nurtec Odt | $500 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-05-06 | Relistor | $107 |
| Averitas Pharma | Meals · 2025-04-26 | Qutenza | $141 |
| Lundbeck | Consulting · 2025-04-08 | Vyepti | $900 |
| Scilex Pharmaceuticals | Meals · 2025-04-05 | Ztlido | $115 |
| Amarin Pharma | Meals · 2025-03-14 | Vascepa | $118 |
See earlier years (2024, 2023, 2022, 2021)
2024: $32,235
| Pfizer | Zavzpret | $16,591 | 15 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $5,131 | 10 payments
|
| Averitas Pharma | Qutenza | $4,534 | 9 payments
|
| Abbvie | Qulipta | $3,202 | 7 payments
|
| Vertex Pharmaceuticals | None | $1,403 | 1 payment
|
| Medtronic | Synchromedii | $1,031 | 10 payments
|
| Abbott Laboratories | Eterna | $171 | 1 payment
|
| Lundbeck | Vyepti | $126 | 2 payments
|
| Tris Pharma | None | $33 | 1 payment
|
| Lilly USA | Emgality | $13 | 1 payment
|
2023: $36,819
| Averitas Pharma | Qutenza | $23,201 | 28 payments
|
| Abbvie | Qulipta | $3,819 | 5 payments
|
| Tris Pharma | Dyanavel Xr | $3,102 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $2,650 | 7 payments
|
| Collegium Pharmaceutical | Belbuca | $2,054 | 3 payments
|
| Impel Pharmaceuticals | Trudhesa | $1,993 | 17 payments
|
2022: $37,104
| GRT US Holding | Qutenza | $12,942 | 27 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $7,713 | 7 payments
|
| Impel Pharmaceuticals | Trudhesa | $6,760 | 5 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $4,484 | 7 payments
|
| RedHill Biopharma | Movantik | $1,725 | 2 payments
|
| Tris Pharma | None | $1,242 | 2 payments
|
| Abbvie | Ubrelvy | $979 | 2 payments
|
| SPR Therapeutics | Sprint Pns System | $596 | 2 payments
|
| Amgen | Aimovig | $375 | 1 payment
|
| Collegium Pharmaceutical | None | $158 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $131 | 1 payment
|
2021: $20,520
| Lilly USA | Reyvow | $7,742 | 8 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $4,900 | 7 payments
|
| AbbVie | Ubrelvy | $2,570 | 2 payments
|
| Amgen | Aimovig | $2,381 | 6 payments
|
| RedHill Biopharma | Movantik | $1,440 | 1 payment
|
| Allergan | Ubrelvy | $1,300 | 6 payments
|
| Boston Scientific | General Pain Management | $108 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $53 | 2 payments
|
| Teva Pharmaceuticals USA | Ajovy | $27 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| PFIZER INC. · Tanezumab Clinical Publication Program · 2021 | This clinician | $4,140 |
| PFIZER INC. · Tanezumab Clinical Publication Program · 2022 | This clinician | $3,200 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1841296779
- Licence
- CA 13587California C13587: Cancelled
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA HSP40441H
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2005-06-24
- NPI last updated
- 2023-04-24
- NPI record certified
- 2023-04-24
This is when the NPI record was last certified, not a medical board exam.